Overview

Investigation of Gender Specificity of the Effects of Furosemide in Healthy Female and Male Volunteers

Status:
Withdrawn
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
In this study the gender specificity of the effects of furosemide in female and male volunteers will be investigated. The main objective is gender-specific comparison of the pharmacokinetic parameters of furosemide in relation to the effect of furosemide (urinary excretion). Secondary objectives are the gender-specific comparison of renal and systemic PAH clearance with the clearance of furosemide and the influence of various genetic polymorphisms on the variability of furosemide pharmacokinetics.
Phase:
Phase 4
Details
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Treatments:
Furosemide